title: PTEN, tau-AP-3, thymidylate synthase immunohistochemistry scoring expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignancy potential and uterine leiomyosarcomas.
abstract: Uterine smooth muscle tumors are frequently classified as benign and malignant. However, an assortment of mitotic counts and nuclear atypia can be indecisive between uncertain malignant potential, and malignant uterine smooth muscle tumors. We applied three immunohistochemical parameters to distinguish between cases of benign, malignant, and those with uncertain malignant histology.
authors: Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan.
authors: L C
authors: LC
authors: Huang
authors: J C
authors: JC
authors: Ye
authors: C H
authors: CH
authors: Hsieh
authors: L M
authors: LM
authors: Chen
authors: T Y
authors: TY
authors: Lin
authors: Y C
authors: YC
authors: Hung
authors: W C
authors: WC
authors: Chang
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D005260:Female; D019337:Hematologic Neoplasms; D006801:Humans; D007150:Immunohistochemistry; D007889:Leiomyoma / Q000378:metabolism / Q000473:pathology*; D007890:Leiomyosarcoma / Q000378:metabolism / Q000473:pathology*; D009214:Myoma / Q000378:metabolism / Q000473:pathology; D051059:PTEN Phosphohydrolase / Q000032:analysis*; D013940:Thymidylate Synthase / Q000032:analysis*; D014594:Uterine Neoplasms / Q000378:metabolism / Q000473:pathology*; D016875:tau Proteins / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D016875:tau Proteins; D013940:Thymidylate Synthase; D051059:PTEN Phosphohydrolase